GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Auxilium Pharmaceuticals, Inc. (AUXL) [hlAlert]

Rating:
Sell AUXL
down 28.35 %

Auxilium Pharmaceuticals, Inc. (AUXL) rated Sell by Merriman Curhan Ford

Posted on: Monday,  Mar 24, 2008  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Sell Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on 03/24/2008, when the stock price was $26.13.
Since then, Auxilium Pharmaceuticals, Inc. has gained 39.57% as of 01/29/2015's recent price of $36.47.
If you would have followed this Merriman Curhan Ford's recommendation on AUXL, you would have lost 28.35% of your investment in 2502 days.

Auxilium Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets products for urology and sexual health. Auxilium markets Testim 1%, a topical testosterone gel, for the treatment of hypogonadism. Auxilium is developing additional Testim line extensions, as well as other products for urology and sexual health, including an enzyme in Phase II for the treatment of Peyronie's Disease that may also prove useful for the treatment of Dupuytren's Disease.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/24/2008 8:25 AM Sell
None
26.13
as of 12/24/2008
1 Week up  0.44 %
1 Month up  13.35 %
3 Months up  18.90 %
1 YTD up  14.02 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy